Mcrb News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mcrb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mcrb Today - Breaking & Trending Today

Seres Therapeutics, Inc. (NASDAQ:MCRB) Given Average Rating of "Moderate Buy" by Analysts

Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Free Report) has earned an average rating of “Moderate Buy” from the five research firms that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month […] ....

Seres Therapeutics Inc , E Fund Management Co , Proshare Advisors , Royal Bank , Fund Management Co , Pricet Rowe Associates Inc , Seres Therapeutics , Get Free Report , Marketbeat Ratings , Fund Management , Share Advisors , Pricet Rowe Associates , Get Free , Seres Therapeutics Daily , Nasdaq Mcrb ,

Seres Therapeutics, Inc. (NASDAQ:MCRB) Receives $13.20 Average Target Price from Analysts

Shares of Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Free Report) have earned a consensus rating of “Moderate Buy” from the five ratings firms that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 year […] ....

Seres Therapeutics Company Profile , Blackrock Inc , Metlife Investment Management , York Mellon Corp , Seres Therapeutics Inc , Swiss National Bank , Jpmorgan Chase Co , Seres Therapeutics , Get Free Report , Marketbeat Ratings , National Bank , New York Mellon Corp , Life Investment Management , Get Free , Seres Therapeutics Daily , Nasdaq Mcrb ,

Analysts Set Seres Therapeutics, Inc. (NASDAQ:MCRB) Price Target at $13.20

Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the five analysts that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month target […] ....

Royal Bank , Coppell Advisory Solutions , Bridgefront Capital , Seres Therapeutics Inc , Raymond James Associates , Seres Therapeutics Company Profile , Seres Therapeutics , Get Free Report , Marketbeat Ratings , Therapeutics Stock Down , Advisory Solutions , Get Free , Seres Therapeutics Daily , Nasdaq Mcrb ,

Seres Therapeutics, Inc. (NASDAQ:MCRB) Receives Consensus Rating of "Moderate Buy" from Brokerages

Shares of Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Free Report) have been given an average recommendation of “Moderate Buy” by the five analysts that are presently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average […] ....

Blackrock Inc , Seres Therapeutics Inc , Avoro Capital Advisors , Vanguard Group Inc , Seres Therapeutics , Get Free Report , Street Corp , Capital Advisors , Hudson Bay Capital Management , Bay Capital Management , Get Free , Seres Therapeutics Daily , Nasdaq Mcrb ,